Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GVHD - Graft-Versus-Host Disease”

1,036 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,036 results

Not applicableNot Yet RecruitingNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274
Testing effectiveness (Phase 2)Study completedNCT01491958
What this trial is testing

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome
Ohio State University Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT02953678
What this trial is testing

Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 71
Early research (Phase 1)UnknownNCT03214289
What this trial is testing

Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease

Who this might be right for
Stem Cell Transplant ComplicationsGraft Versus Host Disease, AcuteFecal Microbiota Transplantation
Sheba Medical Center 4
Early research (Phase 1)Study completedNCT03755414
What this trial is testing

Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndromes+2 more
Washington University School of Medicine 55
Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26
Not applicableLooking for participantsNCT00106925
What this trial is testing

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Who this might be right for
Graft-versus-leukemiaGraft vs Host DiseaseGraft Rejection
National Heart, Lung, and Blood Institute (NHLBI) 1,000
Testing effectiveness (Phase 2)WithdrawnNCT05567406
What this trial is testing

Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy

Who this might be right for
Chronic Graft Versus Host Disease
Kadmon, a Sanofi Company
Early research (Phase 1)Looking for participantsNCT04886726
What this trial is testing

PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis

Who this might be right for
Graft Versus Host Disease
Henry Ford Health System 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04883918
What this trial is testing

ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

Who this might be right for
Acute-graft-versus-host Disease
ASC Therapeutics 60
Not applicableUnknownNCT00751452
What this trial is testing

Citrulline Allo. Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in Children

Who this might be right for
Benign Disease
University Hospital, Clermont-Ferrand 30
Not applicableStudy completedNCT06247891
What this trial is testing

Endocytoscopy of Upper Gastrointestinal Tract in Acute Graft-versus-host Disease: a Pilot Study

Who this might be right for
Endocytoscopy
Ruijin Hospital 14
Testing effectiveness (Phase 2)Study completedNCT01790568
What this trial is testing

Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsNon-Neoplastic Hematologic and Lymphocytic Disorder
University of Michigan Rogel Cancer Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06304025
What this trial is testing

Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment

Who this might be right for
Graft Versus Host Disease
Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle 10
Very early researchStudy completedNCT00612274
What this trial is testing

Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplantation
Yale University 26
Large-scale testing (Phase 3)Not Yet RecruitingNCT06000982
What this trial is testing

Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis

Who this might be right for
GVHD
Shanghai Jiao Tong University School of Medicine 138
Very early researchUnknownNCT04285424
What this trial is testing

FMT for Steroid Resistant Gut Acute GVHD

Who this might be right for
Stem Cell Transplant ComplicationsAcute Graft-Versus-Host DiseaseFecal Microbiota Transplantation
Affiliated Hospital to Academy of Military Medical Sciences 30
Early research (Phase 1)Study completedNCT00806208
What this trial is testing

Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD)

Who this might be right for
Graft-Versus-Host Disease
MedImmune LLC 34
Testing effectiveness (Phase 2)Study completedNCT00006417
What this trial is testing

Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT02172768
What this trial is testing

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease

Who this might be right for
Acute Graft Versus Host Disease Grade II-IVAllogeneic Stem Cell TransplantAcute Myeloid Leucaemia+1 more
Radboud University Medical Center 30
Load More Results